Literature DB >> 16395310

A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.

Christoph Mulert1, Georg Juckel, Ina Giegling, Oliver Pogarell, Gregor Leicht, Susanne Karch, Paraskevi Mavrogiorgou, Hans-Jürgen Möller, Ulrich Hegerl, Dan Rujescu.   

Abstract

An important reason for the interest in P300 event-related potentials are findings in patients with psychiatric disorders like schizophrenia or alcoholism in which attenuations of the P300 amplitude are common findings. The P300 wave has been suggested to be a promising endophenotype for genetic research since attenuations of the amplitude and latency can be observed not only in patients but also in relatives. In parallel, the search for genes involved in the pathogenesis of psychiatric disorders has revealed for both, schizophrenia and alcoholism an association with a DRD3 Ser9Gly polymorphism in a number of studies. In the present study, we have investigated 124 unrelated healthy subjects of German descent and have found diminished parietal and increased frontal P300 amplitudes in Gly9 homozygotes in comparison to Ser9 carriers. This finding suggests a possible role of the DRD3 receptor gene in the interindividual variation of P300 amplitudes. Further studies should address the direct role of the DRD3 Ser9Gly polymorphism in attenuated P300 amplitudes in psychiatric disorders like schizophrenia or alcoholism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395310     DOI: 10.1038/sj.npp.1300984

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  19 in total

1.  Dopamine Genetics and Function in Food and Substance Abuse.

Authors:  K Blum; M Oscar-Berman; D Barh; J Giordano; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-10

2.  Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.

Authors:  Gwyneth Zai; Bonnie Alberry; Janine Arloth; Zsófia Bánlaki; Cristina Bares; Erik Boot; Caroline Camilo; Kartikay Chadha; Qi Chen; Christopher B Cole; Katherine T Cost; Megan Crow; Ibene Ekpor; Sascha B Fischer; Laura Flatau; Sarah Gagliano; Umut Kirli; Prachi Kukshal; Viviane Labrie; Maren Lang; Tristram A Lett; Elisabetta Maffioletti; Robert Maier; Marina Mihaljevic; Kirti Mittal; Eric T Monson; Niamh L O'Brien; Søren D Østergaard; Ellen Ovenden; Sejal Patel; Roseann E Peterson; Jennie G Pouget; Diego L Rovaris; Lauren Seaman; Bhagya Shankarappa; Fotis Tsetsos; Andrea Vereczkei; Chenyao Wang; Khethelo Xulu; Ryan K C Yuen; Jingjing Zhao; Clement C Zai; James L Kennedy
Journal:  Psychiatr Genet       Date:  2016-12       Impact factor: 2.458

3.  Heritability and molecular-genetic basis of the P3 event-related brain potential: a genome-wide association study.

Authors:  Stephen M Malone; Uma Vaidyanathan; Saonli Basu; Michael B Miller; Matt McGue; William G Iacono
Journal:  Psychophysiology       Date:  2014-12       Impact factor: 4.016

Review 4.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

5.  Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects.

Authors:  Andres H Neuhaus; Terry E Goldberg; Youssef Hassoun; John A Bates; Katharine W Nassauer; Serge Sevy; Carolin Opgen-Rhein; Anil K Malhotra
Journal:  Schizophr Res       Date:  2009-04-07       Impact factor: 4.939

Review 6.  Do effectiveness ("real world") studies on antipsychotics tell us the real truth?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-07-11       Impact factor: 5.270

7.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

Review 8.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

Review 9.  Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.

Authors:  Gunvant K Thaker
Journal:  Schizophr Bull       Date:  2008-05-22       Impact factor: 9.306

10.  A new role for endophenotypes in the GWAS era: functional characterization of risk variants.

Authors:  Mei-Hua Hall; Jordan W Smoller
Journal:  Harv Rev Psychiatry       Date:  2010 Jan-Feb       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.